Asset Details
Do you wish to reserve the book?
18F-FDG PET/CT to differentiate malignant necrotic lymph node from benign cystic lesions in the neck
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
18F-FDG PET/CT to differentiate malignant necrotic lymph node from benign cystic lesions in the neck
Do you wish to request the book?
18F-FDG PET/CT to differentiate malignant necrotic lymph node from benign cystic lesions in the neck
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
18F-FDG PET/CT to differentiate malignant necrotic lymph node from benign cystic lesions in the neck
2017
Overview
Objective
Patients presenting with cystic lesions in the neck without obvious signs of malignancy constitute a diagnostic challenge since fine needle aspiration is often insufficient and a diagnosis may not be reached until surgical resection/biopsy is performed. The differential diagnosis of a cystic cervical mass comprises a variety of benign conditions, but malignancy must be ruled out. We examined the diagnostic performance of fluorine-18 fluorodeoxyglucose (
18
F-FDG) PET/CT to identify malignancy.
Methods
We retrospectively included consecutive patients referred from the Department of ENT Head and Neck Surgery for
18
F-FDG PET/CT-scans because of a solitary neck cyst. Scan results were compared to histopathology and follow-up.
Results
The study comprised 58 patients. Twenty patients (34%) were diagnosed with cancer during follow-up. PET/CT suggested malignancy in 34 patients (19 true positive, 15 false positive) and showed no malignancy in 24 (23 true negative, 1 false negative). The sensitivity, specificity, accuracy, positive and negative predictive values were 95% (76–99%), 61% (45–74%), 72% (60–82%), 56% (39–71%), and 96% (80–99%), respectively (95% confidence intervals in brackets). The primary tumor was identified in 14 out of the 20 patients with confirmed cancer. Increased metabolism, as evaluated by PET, was the only imaging characteristic among several others, which associated independently with malignancy in the cystic neck lesions, odds ratio 1.27 (1.07–1.50),
p
= 0.006.
Conclusion
18
F-FDG PET/CT could reliably rule out malignancy (NPV 96%), albeit with a high frequency of false positive scans, requiring further diagnostic work-up. Increased metabolism was the best imaging parameter to differentiate between malignant and benign lesions.
Publisher
Springer Japan
Subject
